PATENT CLAIM ANALYSIS

Application Number: 16252648
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "017600"]

Abstract:
Prodrugs of an NMDA antagonist, (S)-1-phenyl-2-(pyridin-2-yl)ethanamine, useful for the treatment of depression (particularly major depressive disorder) or pain; compositions comprising them, and methods of making them.

Claim (Index 19):
A pharmaceutical composition comprising from 0.10 to 50% by weight of compound that is (S)-1-((S)-2-amino-3-methylbutanoyl)-N-((S)-1-phenyl-2-(pyridin-2-yl)ethyl)pyrrolidine-2-carboxamide, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15034727', '15785654', '15194984', '11977777', '13722740']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6988553864282882
- 35 USC 102 Novelty (BERT): 0.5462948470805565
- Combined Prediction Score: 0.683599332493515
- Mean Citation Score: 271.861012
- Max Citation Score: 385.91602
- Similarity Product: 277.28881020782467

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test